Labiotech.eu

In Depth 25 Feb 2019

Accelerator or Incubator? What to Look for in a Biotech Startup Program

Early stage biotech companies and scientists interested in commercialization need great accelerator programs, not more biotech incubators. Biotech companies and scientists who start out on the road to commercialization may need an accelerator to bring out the entrepreneurial spirit. The incubator and accelerator models are conflated all the time in biotech, much to the fury […]

February 25, 2019 - 5 minutesmins - By External Contributor

stem cell therapy mogrify disley heart disease

Startup Scout 22 Feb 2019

This Biotech’s Algorithm Accelerates Cell Therapy Development

Mogrify is the new kid on the block for cell therapy. Based in Cambridge, UK, it boasts technology that could speed up the development of cell therapies by predicting the best chemical recipe to transform mature adult cells into other cell types. Mission: To use next-generation sequencing and gene expression data to develop more cost-effective […]

February 22, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 22 Feb 2019

French Company to Open Biggest Insect Farm in the World

A Series C round of €110M ($125M) — the largest ever for agriculture technology outside of the USA — will fund the construction of the world’s largest automated insect farm by the French company Ynsect. Ynsect is a company that uses insects to provide protein-rich feed for fish farming, pet food, and even the fertilizer industry. […]

February 22, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 21 Feb 2019

First All-Inclusive Biotech Lab Facility Will Launch in Paris

The young UK company RUNLABS plans to open the first facility where biotech companies can hire a package of lab space, lab services, offices, and even technicians. A common time sink in setting up a biotech company is the sheer amount of administration involved, such as hiring staff, getting insurance, and facilities maintenance. The company […]

February 21, 2019 - 3 minutesmins - By Jonathan Smith

biomX microbiome acne inflammatory bowel disease

News and Trends 21 Feb 2019

Microbiome Biotech Will Use Series B to Bring Treatments to Clinic

The Israeli biotech BiomX has raised €28M ($32M) to advance its treatments for acne and inflammatory bowel disease to the clinical stage. Investor interest is continuing in treatments based on the microbiome, which have the potential to treat a variety of conditions such as chronic inflammatory diseases, and even some forms of cancer. BiomX’s approach […]

February 21, 2019 - 2 minutesmins - By Jonathan Smith

Andreas Schmidt Heidelberg Refresh Meetup header2

Interview 21 Feb 2019

Why an International, Diverse Outlook is Key for Modern Biotechs

In a world that is becoming ever more connected, it is important to embrace globalization and diversity in order to get ahead. This is increasingly more important in biotech companies, according to Andreas Schmidt, CEO of Proteona, who I spoke to at our recent Labiotech Refresh event in Heidelberg. Schmidt is an expert on the […]

February 21, 2019 - 6 minutesmins - By Helen Albert

antibiotic resistance next generation sequencing ares qiagen 1

News and Trends 21 Feb 2019

Qiagen Gets Access to Largest Genetic Database on Antibiotic Resistance

Under a new licensing deal, Qiagen will gain access to a big genetics database from Vienna-based Ares Genetics, which could help tackle the global health crisis of antibiotic resistance. Antibiotic resistance is a major health concern that is growing fast. One reason for this is that people are often prescribed the wrong antibiotic for […]

February 21, 2019 - 3 minutesmins - By Jonathan Smith

autoimmune disorder eosinophilic esophagitis allergy milk calypso biotech

News and Trends 20 Feb 2019

Inflammatory Disease Treatment Backed by €20M Series A

The Swiss company Calypso Biotech has raised a sizeable €20M to fund its immunotherapy for an allergy-related inflammatory disease. The Series A round will help to develop Calypso’s antibody treatment for eosinophilic esophagitis, a condition where patients have an inflamed esophagus and difficulty swallowing. This condition is often linked with allergies to food, such as […]

February 20, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 19 Feb 2019

From Saving Endangered Rhinos to Enabling Lab-Grown Meat

Researchers at the University of Oslo are building a biobank of animal cells, the first of its kind, to help researchers develop lab-grown meat and contribute to the conservation of endangered species. Gareth Sullivan became familiar with stem cell technology while working in the group of Ian Wilmut, the scientist behind cloning Dolly the sheep. […]

February 19, 2019 - 4 minutesmins - By Clara Rodríguez Fernández

acne s biomedic skinbiotherapeutics skin microbiome

News and Trends 19 Feb 2019

Skin Microbiome Biotechs Get Funding Boost

Two major skin microbiome companies have received investments this week: the Belgian company S-Biomedic, which is developing a probiotic acne treatment, and the UK biotech SkinBioTherapeutics, which is targeting eczema. A lot of attention goes to the gut microbiome when talking about probiotic disease treatments, but skin bacteria may also have potential, as these […]

February 19, 2019 - 2 minutesmins - By Jonathan Smith

In Depth 19 Feb 2019

How New Microbiome Diagnostic Technologies Can Save Lives

With the rise of a whole new field of research around the microbiome, what role are new technologies to identify microorganisms playing in the future of healthcare? Traditionally, microbes have been seen solely as a threat. But in the last few years, microbiome research has started to shift this view. Today, we know certain microorganisms […]

February 19, 2019 - 5 minutesmins - By Clara Rodríguez Fernández

tuberculosis suicide cnrs embl Francis Crick antibiotic resistance immune

News and Trends 18 Feb 2019

Tuberculosis Treatment Kills Bacteria with Their Own Suicide Toxin

A European academic research collaboration has found a new potential weapon against antibiotic-resistant tuberculosis: its own toxins. Many types of bacteria, such as the pathogen responsible for the deadly lung disease tuberculosis, Mycobacterium tuberculosis, use toxins to stay alive. For example, these toxins can be useful when the bacteria are starved or infected by viruses, […]

February 18, 2019 - 3 minutesmins - By Jonathan Smith

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Accelerator or Incubator? What to Look for in a Biotech Startup Program

This Biotech’s Algorithm Accelerates Cell Therapy Development

French Company to Open Biggest Insect Farm in the World

First All-Inclusive Biotech Lab Facility Will Launch in Paris

Microbiome Biotech Will Use Series B to Bring Treatments to Clinic

Why an International, Diverse Outlook is Key for Modern Biotechs

Qiagen Gets Access to Largest Genetic Database on Antibiotic Resistance

Inflammatory Disease Treatment Backed by €20M Series A

From Saving Endangered Rhinos to Enabling Lab-Grown Meat

Skin Microbiome Biotechs Get Funding Boost

How New Microbiome Diagnostic Technologies Can Save Lives

Tuberculosis Treatment Kills Bacteria with Their Own Suicide Toxin

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!